Drug Shortage Report for THEO ER

Last updated on 2024-10-31 History
Report ID 240630
Drug Identification Number 02360128
Brand name THEO ER
Common or Proper name THEO ER
Company Name AA PHARMA INC
Market Status MARKETED
Active Ingredient(s) THEOPHYLLINE
Strength(s) 600MG
Dosage form(s) TABLET (EXTENDED-RELEASE)
Route of administration ORAL ORAL
Packaging size 100 BTL
ATC code R03DA
ATC description OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2024-10-18
Estimated end date 2024-10-31
Actual end date 2024-10-29
Shortage status Resolved
Updated date 2024-10-31
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 1165 CREDITSTONE ROAD
VAUGHAN, ONTARIO
CANADA L4K 4N7
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2024-10-31 French Compare
v6 2024-10-31 English Compare
v5 2024-10-24 French Compare
v4 2024-10-24 English Compare
v3 2024-10-19 English Compare
v2 2024-10-18 French Compare
v1 2024-10-18 English Compare

Showing 1 to 7 of 7